3D-DCE MR灌注成像与HRCT容积成像对慢性阻塞性肺疾病肺功能评估的对照研究被引量：1

3D-DCE MR Perfusion Imaging Versus HRCT: Pulmonary Functional Loss Assessment of COPD

导出

摘要目的比较慢性阻塞性肺疾病(COPD)患者MRI灌注值与HRCT容积参数的相关性及其用于评估肺功能的可行性。方法 62例COPD患者分别进行PFT、HRCT及MRI检查。后处理软件自动计算出总肺体积(TLV),设定吸气末阈值<-950 HU为肺气肿区,得出总肺气肿体积(TEV),肺气肿指数(EI)为TEV与TLV的比值。用3D并行采集梯度脉冲序列获得MRI灌注图像原始数据,通过Functool软件得到灌注缺损区信号强度值(SIPD),相对正常肺组织的信号强度(SInormal),并计算得到灌注缺损区与相对正常肺组织的信号强度之比(RSI)。运用Spearman相关分析评价各MRI灌注值与HRCT容积参数的相关性。结果在所有COPD患者中,RSI分别与TLV、TEV和EI有相关性(r=-0.312,P=0.013;r=-0.466,P<0.001;r=-0.476,P<0.001);而SIPD分别与TLV、TEV、EI的相关性稍弱(r=-0.306,P=0.015;r=-0.400,P=0.001;r=-0.394,P=0.002)。在Ⅱ级COPD患者中,RSI分别与TEV和EI有强相关性(r=-0.583,P=0.014;r=-0.623,P=0.008);而SIPD与TLV、TEV和EI有中等强度的相关性(r=-0.495,P=0.043;r=-0.586,P=0.013;r=-0.534,P=0.027)。在Ⅳ级COPD患者中,TLV分别与SIPD、RSI有显著的相关性(r=-0.594,P=0.042;r=-0.713,P=0.009)。而Ⅰ、Ⅲ级COPD患者的MRI灌注与HRCT容积各参数之间无相关性。MRI灌注值与肺功能指标的相关性较HRCT容积量化参数与肺功能指标的相关性强,RSI与FVC(r=0.529,P<0.001)、%FEV1(r=0.655,P<0.001)的相关性好于EI与FVC(r=-0.372,P=0.003)或%FEV1(r=-0.532,P<0.001)的相关性。结论 MRI灌注值与HRCT容积参数间存在明显负的相关性,RSI与EI相比,能更好地评估肺功能。 Objective To prospectively compare values of 3D dynamic contrast-enhanced（DCE） MR perfusion imaging with density-based HRCT volumetric parameters in COPD for pulmonary functional loss assessment.Methods 62 patients with COPD underwent PFT,HRCT and 3D-DCE MR perfusion imaging.From the volumetric CT data,the total lung volume（TLV） was calculated automatically and the total emphysema volume（TEV） was obtained by applying density threshold of-950 HU.The TEV/ TLV was calculated as emphysema index（EI）.The 3D MR perfusion data was post processed using Functool,signal intensity of perfusion defects（SIPD）,signal intensity of normal lung perfusion（SInormal） were obtained by selecting region of interest（ROI） and the signal intensity ratio（RSI） of the perfusion defects and normal lung perfusion was calculated.The correlation between the perfusion values of 3D-DCE MRI and the HRCT volumetric parameters was assessed using Spearman correlation analysis.Results The RSI showed good correlation with the TLV,TEV and EI（r=-0.312,P=0.013;r=-0.466,P0.001;r=-0.476,P0.001）for all patients with COPD.In contrast,there was little lower correlation between SIPD and TLV,TEV,EI（r=-0.306,P=0.015;r=-0.400,P=0.001;r=-0.394,P=0.002）.For GOLD Ⅱ patients,the RSI had strong correlation with TEV and EI（r=-0.583,P=0.014;r=-0.623,P=0.008）;the SIPD had moderate correlation with TLV,TEV and EI（r=-0.495,P=0.043;r=-0.586,P=0.013;r=-0.534,P=0.027.The correlation coefficient between the TLV values and the SIPD was r=-0.594（P=0.042）,between the TLV values and the RSI was r=-0.713（P=0.009） for GOLD IV patients.However,there was no correlation between the perfusion values of 3D-DCE MRI and the HRCT volumetric parameters for patients as GOLD Ⅰ and Ⅲ.Correlation between RSI and FVC（r=0.529,P 0.001） and between RSI and %FEV1（r= 0.655,P 0.0001） was better than that between EI and either FVC（r =-0.372,P =0.003） or %FEV1（r =-0.532,P 0.001）.Conclusion There was significant inverse correlation between values of 3D-DCE MR perfusion imaging and HRCT volumetric parameters in COPD.The RSI may provide a more sensitive assessment for pulmonary functional loss of COPD patients than the EI.

作者夏艺管宇范丽张铁峰刘士远李兵于红

机构地区上海第二军医大学附属长征医院影像科

出处《临床放射学杂志》 CSCD 北大核心 2013年第5期733-737,共5页 Journal of Clinical Radiology

基金国家自然基金青年基金项目(编号:81000602) 上海市自然基金项目(编号:10ZR1438900)

关键词慢性阻塞性肺疾病肺灌注磁共振成像体层摄影术 X线计算机肺功能检查 COPD MR perfusion imaging HRCT PFT

分类号 R563.9 [医药卫生—呼吸系统]

引文网络
相关文献

参考文献8

1GOLD: global strategy for tile diagnosis, management, and prewm- tion of chronic obstructive pulmonary disease. Executive summary. http://www, goldcopd, org. Updated 2008. Accessed October 20, 2009,.
2Mannino DM,Dohel"ty DE, Sonia Buist A, et al. Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherusclerosis Risk in Communities( ARIC ) study. Respir Med ,2006,100 : 115.
3I,ey-Zaporozhan J, l,ey S, Kauezor |tU, et al. Morphological and func- tional imaging in COPD with CT and MRI: present and filture. Eur Radiol, 2008,18 : 510.
4钟小宁.对慢性阻塞性肺疾病肺血管改变的几点认识[J].中华结核和呼吸杂志,2011,34(4):248-250. 被引量：15
5Snider GL, Kleinerman J .Thurlbeck WM, et al. The definition of em physema. Report of a National Heart, Lung, and Blood Institute Division of Lung Diseases Workshop. Am Rev Respir Dis, 1985 132,182.
6Jang YM, Oh YM, Seo JB, et al. Quantitatively assessed dynamic contrast enhanced magnetic resonance imaging in patients with chro-nic ol:struetive puhnonary disease: correlation of perihsion parame- ters with pulmonary function test and quantitative computed tomo- graphy, havest Radio1,2008,43:403.
7Pauls S, Gulkin D, Feuerlein S, et a|. Assessment of COPD severity by computed tomography: correlation with lung fnnctional testing. Clinical Imaging ,2010,34 : 172.
8Kessler R, Failer M, Fourgaut G, et al. Predictive faeto: of hospitali- zation hlr acute exacerbation in a series of 64 patients with chronie obsmmtive puhnonary disease. Am J Respir Crit Care Med, 1999, 159:158.

二级参考文献19

1刘积锋,钟小宁,张健全,陈罡.血管内皮生长因子与慢性支气管炎并肺气肿大鼠早期肺动脉重塑关系的研究[J].中华结核和呼吸杂志,2006,29(5):353-354. 被引量：13
2钟小宁,郭韶梅.慢性支气管炎与肺气肿大鼠肺血管炎症的实验研究[J].中华结核和呼吸杂志,2006,29(7):435-439. 被引量：22
3张建全,钟小宁,蒋明,柳广南.慢性支气管炎、肺气肿时肺动脉高压与肺血管壁改建与炎症的关系[J].中国病理生理杂志,2006,22(9):1811-1815. 被引量：29
4Chaouat A,Bugnet AS,Kadaoui N,et al.Severe pulmonary hypertension and chronic obstructive pulmonary disease.Am J Respir Crit Care Med,2005,172:189-194.
5Wright JL,Levy RD,Churg A.Pulmonary hypertension in chronic obstructive pulmonary disease:current theories of pathogenesis and their implications for treatment.Thorax,2005,60:605-609.
6Santos S,Peinado VI,Ramírez J,et al.Characterization of pulmonary vascular remodeling in smokers and patients with mild COPD.Eur Respir J,2002,19:632-638.
7Fabbri LM,Luppi F,Beghé B,et al.Update in chronic obstructive pulmonary disease 2005.Am J Respir Crit Care Med,2006,173:1056-1065.
8Corrado A,Renda T,Bertini S.Long-term oxygen therapy in COPD:evidences and open questions of current indications.Monaldi Arch Chest Dis,2010,73:34-43.
9Schiess R,Senn O,Fischler M,et al.Tobacco smoke:a risk factor for pulmonary arterial hypertension? A case-control study.Chest,2010,138:1086-1092.
10Nadziejko C,Fang K,Bravo A,et al.Susceptibility to pulmonary hypertension in inbred strains of mice exposed to cigarette smoke.J Appl Physiol,2007,102:1780-1785.